PPARγ expression is low in SSc lesions [97], and in SSc animal models, ligand activation of PPARγ reduces both TGFβ-dependent fibrogenesis and fibroblast hyperactivation [98]. This evidence concerns the gene PPARG and systemic sclerosis.